What Role Does Diagnostics Play in the Choroidal Neovascularization Market?

Diagnostics are essential to the choroidal neovascularization market. Early detection of CNV is critical to prevent irreversible vision loss. Optical coherence tomography (OCT) and fluorescein angiography are standard tools for diagnosing and monitoring CNV.

The choroidal neovascularization market benefits from advances in imaging technology. OCT angiography offers non-invasive visualization of blood vessels, improving diagnosis and monitoring. AI-assisted imaging is emerging, helping clinicians detect subtle changes.

Diagnostics also guide treatment decisions, including when to initiate or adjust anti-VEGF therapy. Remote monitoring and telemedicine are expanding access to specialist care.

Challenges include cost, availability of advanced imaging in some regions, and the need for trained specialists. However, as imaging technology improves and access expands, diagnostics are expected to support growth in the choroidal neovascularization market.

People Also Ask

  • How is CNV diagnosed? OCT and fluorescein angiography are commonly used to detect and monitor choroidal neovascularization.

  • What is OCT angiography? It is a non-invasive imaging technique that visualizes blood vessels in the retina without dye injection.

Tags: #OCT #Angiography #CNVDiagnostics #Ophthalmology #ImagingTechnology #RetinaHealth

Leia mais